肠道微生物群在眼表疾病中的研究现状-《天津医科大学学报》

参考文献/References:

[1] VRANCKEN G， GREGORY A C， HUYS G R B， et al. Synthetic ecology of the human gut microbiota[J]. Nat Rev Microbiol，2019，17（12）：754-763.
[2] PITTAYANON R， LAU J T， LEONTIADIS G I， et al. Differences in gut microbiota in patients with vs without inflammatory bowel diseases： a systematic review[J]. Gastroenterology，2020，158（4）：930-946.
[3] NUZUM N D， LOUGHMAN A， SZYMLEK GAY E A，et al. Gut microbiota differences between healthy older adults and individuals with Parkinson′s disease： a systematic review[J]. Neurosci Biobehav Rev，2020，112：227-241.
[4] WANG Y， ZHAO J， QIN Y， et al. The specific alteration of gut microbiota in diabetic kidney diseases-a systematic review and meta-analysis[J]. Front Immunol，2022，13：219-222.
[5] TRAN S M， MOHAJERI M H. The role of gut bacterial metabolites in brain development， aging and disease[J]. Nutrients， 2021，13（3）：732.
[6] ZYSSET BURRI D C， MORANDI S， HERZOG E L， et al. The role of the gut microbiome in eye diseases[J]. Prog Retin Eye Res，2022， 5：111-117.
[7] THAKUR S， SHEPPARD J D. Gut microbiome and its influence on ocular surface and ocular surface diseases[J]. Eye Contact Lens，2022，48（7）：278-282.
[8] MATIJA?譒I■ M， ME?譒TROVI■ T， ■IP■I■ PALJETAK H， et al. Gut microbiota beyond Bacteria—mycobiome， virome， archaeome， and eukaryotic parasites in IBD[J]. Int J Mol Sci，2020，21（8）：2668.
[9] STOJANOV S， BERLEC A， STRUKELJ B. The influence of probiotics on the firmicutes/ bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease[J]. Eye Contact Lens，2020，20（15）：98-101.
[10] TURNBAUGH P J， LEY R E， MAHOWALD M A， et al. An obesity associated gut microbiome with increased capacity for energy harvest[J]. Nature，2006，444：1027-1031.
[11] GOODRICH J K， WATERS J L， POOLE A C， et al. Human genetics shape the gut microbiome[J]. Cell，2014，159：789-799.
[12] SOKO L H，LANDMAN C，SEKSIK P，et al. Fecal microbiota transplantation to maintain remission in Crohn′s disease：a pilo trandomized controlled study[J]. Microbiome，2020，8：12-15.
[13] MAEDA Y， KURAKAWA T， UMEMOTO E， et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine[J]. Arthritis Rheumatol，2018，68：2646-2661.
[14] ZAHEER M， WANG C， BIAN F，et al. Protective role of commensal bacteria in sj?觟gren syndrome[J]. Autoimmun，2018，93：45-56.
[15] WANG C， SCHAEFER L， BIAN F， et al. Dysbiosis modulates ocular surface inflflammatory response to liposaccharide[J]. Invest Ophthalmol Vis Sci，2019，60：4224-4233.
[16] MENDEZ R， WATANE A， FARHANGI M， et al. Gut microbial dysbiosis in individuals with Sjogren′s syndrome[J]. Microb Cell Fact，2020，19：90.
[17] VAN DER MEULEN T A， HARMSEN HJM， VILA A V， et al. Shared gut， but distinct oral microbiota composition in primary Sjogren′s syndrome and systemic lupus erythematosus[J]. Autoimmun， 2019，97：77-87.
[18] SCHAEFER L， HERNANDEZ H， COATS R A， et al. Gut-derived butyrate suppresses ocular surface inflammation[J]. Sci Rep，2022， 12（1）：4512.
[19] YOON C H， RYU J S， MOON J， et al. Association between aging-dependent gut microbiomedysbiosis and dry eye severity in C57BL/6 male mouse model： a pilot study[J]. BMC Microbiol， 2021，21：106.
[20] OSAE E A， STEVEN P， REDFERN R， et al. Dyslipidemia and meibomian gland dysfunction： utility of ipidomics and experimental prospects with a diet induced obesity mouse model[J]. Int J Mol Sci，2019，20：3505.
[21] DAVANI-DAVARI D， NEGAHDARIPOUR M， KARIMZADEH I， et al. Prebiotics： defifinition， types， sources， mechanisms， and cli-nical applications[J]. Foods，2019，8：92.
[22] CHOI S H ，OH J W， RYU J S，et al. IRT5 Probiotics changes immune modulatory protein expression in the extraorbital lacrimal glands of an autoimmune dry eye mouse model[J]. Invest Opthalmol Vis Sci，2020，61：42.
[23] VIJAY A， ASTBURY S， LE ROY C， et al. The prebiotic effects of omega-3 fatty acid supplementation： a six-week randomised intervention trial[J]. Gut Microbes，2021，13：1-11.
[24] KAWASHIMA M， TSUNO S， MATSUMOTO M， et al. Hydrogen-producing milk to prevent reduction in tear stability in persons using visual display terminals[J]. Ocul Surf ，2019，17：714-721.
[25] PASTOR VILLAESCUSA B， HURTADO J A， GIL CAMPOS M， et al. Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health： a random clinical trial in nursing women[J]. Benef Microbes，2020，11：235-244.
[26] BANERJEE A， NELSON D E. How Chlamydia trachomatis conquered gut microbiome-derived antimicrobial compounds and found a new home in the eye[J]. Proc Natl Acad Sci U S A，2019，116（25）：12136-12138.
[27] WU M， LIU J， LI F. Antibiotic-induced dysbiosis of gut microbiota impairs corneal development in postnatal mice by affecting CCR2 negative macrophage distribution[J]. Mucosal Immunol，2020，13（1）：47-63.
[28] LIU J， WU M， HE J，et al. Antibiotic-induced dsbiosis of gut microbiota impairs corneal nerve regeneration by affecting CCR2-negative macrophage distribution[J]. Am J Pathol， 2018，188（12）：2786-2799.
[29] JAYASUDHA R， CHAKRAVARTHY S K， PRASHANTHI G S， et al. Alterations in gut bacterial and fungal microbiomes are associated with bacterial Keratitis， an inflammatory disease of the human eye[J]. Bioscience，2018，43： 835-856.
[30] SHIVAJI S. A systematic review of gut microbiome and ocular inflflammatory diseases： are they associated?[J]. Indian J Ophthalmol，2021，69：535-542.
[31] KALYANA CHAKRAVARTHY S， JAYASUDHA R， RANJITH K， et al. Alterations in the gut bacterial microbiome in fungal Keratitis patients[J]. PLoS One，2018，13：639-640.
[32] FILIPPELLI M， DELL OMO R， AMORUSO A，et al. Intestinal microbiome： a new target for chalaziosis treatment in children[J] Eur J Pediatr，2021，180（4）：1293-1298.
[33] WANG C， ZAHEER M， BIAN F， et al. Sj?觟gren-like lacrimal kratoconjunctivitis in germ-free mice[J]. Mol Sci，2018，19：595-599.

[1]王子荀综述,秦秀虹审校.肠道微生物群在眼表疾病中的研究现状[J].天津医科大学学报,2024,30(01):101-104.[doi:10.20135/j.issn.1006-8147.2024.01.0101]

点击复制

肠道微生物群在眼表疾病中的研究现状(PDF)

分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

文章信息/Info

参考文献/References:

相似文献/References:

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics